Logo image of NOVC.CA

NOVA CANNABIS INC (NOVC.CA) Stock Fundamental Analysis

TSX:NOVC - Toronto Stock Exchange - CA66980W1041 - Common Stock - Currency: CAD

1.75  0 (0%)

Fundamental Rating

4

Overall NOVC gets a fundamental rating of 4 out of 10. We evaluated NOVC against 16 industry peers in the Specialty Retail industry. The financial health of NOVC is average, but there are quite some concerns on its profitability. NOVC is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

NOVC had positive earnings in the past year.
In the past year NOVC had a positive cash flow from operations.
NOVC had negative earnings in 4 of the past 5 years.
In multiple years NOVC reported negative operating cash flow during the last 5 years.
NOVC.CA Yearly Net Income VS EBIT VS OCF VS FCFNOVC.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M -20M

1.2 Ratios

NOVC has a Return On Assets (2.32%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 5.32%, NOVC is in line with its industry, outperforming 56.25% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 7.21%, NOVC is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
ROA 2.32%
ROE 5.32%
ROIC 7.21%
ROA(3y)-8.27%
ROA(5y)-6.93%
ROE(3y)-17.5%
ROE(5y)-14.76%
ROIC(3y)N/A
ROIC(5y)N/A
NOVC.CA Yearly ROA, ROE, ROICNOVC.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600

1.3 Margins

Looking at the Profit Margin, with a value of 1.14%, NOVC is in line with its industry, outperforming 43.75% of the companies in the same industry.
Looking at the Operating Margin, with a value of 4.17%, NOVC is in line with its industry, outperforming 56.25% of the companies in the same industry.
NOVC's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 24.83%, NOVC is doing worse than 75.00% of the companies in the same industry.
NOVC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.17%
PM (TTM) 1.14%
GM 24.83%
OM growth 3Y28.41%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.26%
GM growth 5YN/A
NOVC.CA Yearly Profit, Operating, Gross MarginsNOVC.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NOVC is destroying value.
The number of shares outstanding for NOVC remains at a similar level compared to 1 year ago.
Compared to 5 years ago, NOVC has more shares outstanding
Compared to 1 year ago, NOVC has an improved debt to assets ratio.
NOVC.CA Yearly Shares OutstandingNOVC.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
NOVC.CA Yearly Total Debt VS Total AssetsNOVC.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 2.85 indicates that NOVC is not a great score, but indicates only limited risk for bankruptcy at the moment.
NOVC has a Altman-Z score (2.85) which is comparable to the rest of the industry.
The Debt to FCF ratio of NOVC is 5.15, which is a neutral value as it means it would take NOVC, 5.15 years of fcf income to pay off all of its debts.
NOVC's Debt to FCF ratio of 5.15 is in line compared to the rest of the industry. NOVC outperforms 56.25% of its industry peers.
NOVC has a Debt/Equity ratio of 0.94. This is a neutral value indicating NOVC is somewhat dependend on debt financing.
The Debt to Equity ratio of NOVC (0.94) is worse than 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 5.15
Altman-Z 2.85
ROIC/WACC0.92
WACC7.88%
NOVC.CA Yearly LT Debt VS Equity VS FCFNOVC.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

2.3 Liquidity

NOVC has a Current Ratio of 1.96. This is a normal value and indicates that NOVC is financially healthy and should not expect problems in meeting its short term obligations.
NOVC has a Current ratio of 1.96. This is in the better half of the industry: NOVC outperforms 75.00% of its industry peers.
NOVC has a Quick Ratio of 1.07. This is a normal value and indicates that NOVC is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of NOVC (1.07) is better than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.07
NOVC.CA Yearly Current Assets VS Current LiabilitesNOVC.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

7

3. Growth

3.1 Past

NOVC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 155.95%, which is quite impressive.
NOVC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.84%.
Measured over the past years, NOVC shows a very strong growth in Revenue. The Revenue has been growing by 60.01% on average per year.
EPS 1Y (TTM)155.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.05%
Revenue 1Y (TTM)9.84%
Revenue growth 3Y60.01%
Revenue growth 5YN/A
Sales Q2Q%8.05%

3.2 Future

The Earnings Per Share is expected to grow by 45.10% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 14.38% on average over the next years. This is quite good.
EPS Next Y-26.32%
EPS Next 2Y45.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.23%
Revenue Next 2Y10.06%
Revenue Next 3Y13.72%
Revenue Next 5Y14.38%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
NOVC.CA Yearly Revenue VS EstimatesNOVC.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
NOVC.CA Yearly EPS VS EstimatesNOVC.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.1 -0.1 0.2

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 29.17, NOVC can be considered very expensive at the moment.
NOVC's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of NOVC to the average of the S&P500 Index (29.62), we can say NOVC is valued inline with the index average.
With a Price/Forward Earnings ratio of 8.58, the valuation of NOVC can be described as very reasonable.
Based on the Price/Forward Earnings ratio, NOVC is valued cheaply inside the industry as 81.25% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of NOVC to the average of the S&P500 Index (22.70), we can say NOVC is valued rather cheaply.
Industry RankSector Rank
PE 29.17
Fwd PE 8.58
NOVC.CA Price Earnings VS Forward Price EarningsNOVC.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NOVC is valued a bit cheaper than the industry average as 62.50% of the companies are valued more expensively.
68.75% of the companies in the same industry are more expensive than NOVC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.23
EV/EBITDA 7.02
NOVC.CA Per share dataNOVC.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

NOVC's earnings are expected to grow with 45.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.1%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

NOVC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NOVA CANNABIS INC

TSX:NOVC (10/22/2024, 7:00:00 PM)

1.75

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-01 2024-08-01/amc
Earnings (Next)11-06 2024-11-06
Inst Owners8.38%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap108.64M
Analysts85
Price Target3.57 (104%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-77.12%
Min EPS beat(2)-119.61%
Max EPS beat(2)-34.64%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-4.08%
Min Revenue beat(2)-8.2%
Max Revenue beat(2)0.04%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.45%
PT rev (3m)-3.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-60%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.79%
Valuation
Industry RankSector Rank
PE 29.17
Fwd PE 8.58
P/S 0.4
P/FCF 9.23
P/OCF 7.3
P/B 1.89
P/tB 3.26
EV/EBITDA 7.02
EPS(TTM)0.06
EY3.43%
EPS(NY)0.2
Fwd EY11.66%
FCF(TTM)0.19
FCFY10.84%
OCF(TTM)0.24
OCFY13.69%
SpS4.33
BVpS0.93
TBVpS0.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.32%
ROE 5.32%
ROCE 10.02%
ROIC 7.21%
ROICexc 8.01%
ROICexgc 10.56%
OM 4.17%
PM (TTM) 1.14%
GM 24.83%
FCFM 4.39%
ROA(3y)-8.27%
ROA(5y)-6.93%
ROE(3y)-17.5%
ROE(5y)-14.76%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y75.18%
ROICexcg growth 5YN/A
ROICexc growth 3Y62.97%
ROICexc growth 5YN/A
OM growth 3Y28.41%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.26%
GM growth 5YN/A
F-Score6
Asset Turnover2.03
Health
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 5.15
Debt/EBITDA 2.4
Cap/Depr 27.32%
Cap/Sales 1.15%
Interest Coverage 250
Cash Conversion 66.01%
Profit Quality 384.37%
Current Ratio 1.96
Quick Ratio 1.07
Altman-Z 2.85
F-Score6
WACC7.88%
ROIC/WACC0.92
Cap/Depr(3y)71.34%
Cap/Depr(5y)115.14%
Cap/Sales(3y)4.44%
Cap/Sales(5y)14.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)155.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.05%
EPS Next Y-26.32%
EPS Next 2Y45.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.84%
Revenue growth 3Y60.01%
Revenue growth 5YN/A
Sales Q2Q%8.05%
Revenue Next Year5.23%
Revenue Next 2Y10.06%
Revenue Next 3Y13.72%
Revenue Next 5Y14.38%
EBIT growth 1Y543.68%
EBIT growth 3Y105.47%
EBIT growth 5YN/A
EBIT Next Year96.36%
EBIT Next 3Y64.15%
EBIT Next 5Y46.65%
FCF growth 1Y153.12%
FCF growth 3Y38.04%
FCF growth 5YN/A
OCF growth 1Y302.91%
OCF growth 3Y1.14%
OCF growth 5YN/A